« Revenue Challenged Big Pharma Reveal Hopes to Cope | Main | Sigma-Aldrich to Acquire BioReliance »

01/06/2012

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b0162ff1f48d9970d

Listed below are links to weblogs that reference 2011 Final FDA Drug Approval Statistics:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

Terry McCormick

It is not surprising as Pharma has been actively transforming itself in diverse ways, depending on each firm's strategy. As above, the focus on safety now starts far earlier, reducing later "surprises" in PIII (and hopefully post-approval.) Other firms are unraveling the basis for disease through improved R&D "algorithms" and approaches that also may begin to show fruit. Such improvements may have caused an observed shift in improved innovation in approved drugs 3-4 years ago.


This progress is balanced against strong headwinds that persist, based on what society is willing to pay for life extension and enhancement.

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

April 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30      

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada